IVCVLGMar 21, 2022

Survival Analysis for Idiopathic Pulmonary Fibrosis using CT Images and Incomplete Clinical Data

arXiv:2203.11391v16 citationsh-index: 12
Originality Incremental advance
AI Analysis

This work addresses the problem of predicting survival for patients with Idiopathic Pulmonary Fibrosis, a progressive lung disease, by handling incomplete clinical data, which is incremental as it builds on existing methods with a novel integration approach.

The researchers tackled survival prediction for Idiopathic Pulmonary Fibrosis patients by developing a multi-modal method that combines CT images and clinical data, using neural networks and memory banks with a probabilistic model for missing data imputation, resulting in significantly better performance in terms of concordance index and integrated Brier score compared to baselines.

Idiopathic Pulmonary Fibrosis (IPF) is an inexorably progressive fibrotic lung disease with a variable and unpredictable rate of progression. CT scans of the lungs inform clinical assessment of IPF patients and contain pertinent information related to disease progression. In this work, we propose a multi-modal method that uses neural networks and memory banks to predict the survival of IPF patients using clinical and imaging data. The majority of clinical IPF patient records have missing data (e.g. missing lung function tests). To this end, we propose a probabilistic model that captures the dependencies between the observed clinical variables and imputes missing ones. This principled approach to missing data imputation can be naturally combined with a deep survival analysis model. We show that the proposed framework yields significantly better survival analysis results than baselines in terms of concordance index and integrated Brier score. Our work also provides insights into novel image-based biomarkers that are linked to mortality.

Code Implementations2 repos
Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes